BioVie, Inc. (BIVI) financial statements (2020 and earlier)

Company profile

Business Address 2120 COLORADO AVE.
LOS ANGELES, CA 90404
State of Incorp. NV
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3340465124267333
Cash and cash equivalents3340465124267333
Prepaid expense    72 
Other current assets551334     
Other undisclosed current assets   (0)   
Total current assets:554674465131269333
Noncurrent Assets
Property, plant and equipment   (280)   
Intangible assets, net (including goodwill)1,7861,9002,1302,3592,588 
Goodwill346346346346346  
Intangible assets, net (excluding goodwill)1,4401,5551,7842,0132,243  
Other undisclosed noncurrent assets   280   
Total noncurrent assets:1,7861,9002,1302,3592,588  
Other undisclosed assets   0   
TOTAL ASSETS:2,3402,5742,1752,3642,719269333
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,0854431,238596793324161
Accounts payable1,0854438844712941 
Employee-related liabilities  354125500323161
Due to related parties30  3510  
Other undisclosed current liabilities3,269      
Total current liabilities:4,3844431,238631803324161
Noncurrent Liabilities
Liabilities, other than long-term debt  576173   
Accounts payable and accrued liabilities   173   
Due to related parties  576    
Other undisclosed noncurrent liabilities  250403   
Total noncurrent liabilities:  826576   
Total liabilities:4,3844432,0641,207803324161
Stockholders' equity
Stockholders' equity attributable to parent, including:(2,044)2,1311111,1571,916(54)171
Common stock151109999
Additional paid in capital19,4729,3424,8703,4832,912514514
Accumulated deficit(21,517)(7,262)(4,769)(2,335)(1,004)  
Other undisclosed stockholders' equity attributable to parent   0 (577)(352)
Other undisclosed stockholders' equity  (0)    
Total stockholders' equity:(2,044)2,1311111,1571,916(54)171
Other undisclosed liabilities and equity  0    
TOTAL LIABILITIES AND EQUITY:2,3402,5742,1752,3642,719269333

Income statement (P&L) ($ in thousands)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Gain on disposition of assets for financial service operations7,759 
Net investment income 51 223   
Gross profit:7,75951 223   
Operating expenses(2,921)(2,497)(2,372)(1,554)(432)(233)(322)
Other operating expense, net
(Other Expenses)
     (0)(0)
Other undisclosed operating loss(7,759)(51) (223)   
Operating loss:(2,921)(2,497)(2,372)(1,554)(432)(467)(323)
Interest and debt expense(3,499)(0)(41)222(0)  
Loss before gain (loss) on sale of properties:(6,419)(2,497)(2,413)(1,332)(432)(467)(323)
Other undisclosed net income7,759530    
Net income (loss):1,340(2,444)(2,413)(1,332)(432)(467)(323)
Other undisclosed net income (loss) attributable to parent  (21)102341
Net income (loss) available to common stockholders, diluted:1,340(2,444)(2,434)(1,331)(432)(233)(322)

Comprehensive Income ($ in thousands)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net income (loss):1,340(2,444)(2,413)(1,332)(432)(467)(323)
Comprehensive income (loss), net of tax, attributable to parent:1,340(2,444)(2,413)(1,332)(432)(467)(323)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: